CSL leaders from across R&D and Business Development will be in Shanghai on August 25, together with BFC Group Ltd , to host a Partnering Forum bringing together innovators and investors to discuss emerging science, our therapeutic area priorities, and our approach to external innovation. For entrepreneurs and biotechnology companies working in immunology, hematology, cardiovascular and renal disease, this is an opportunity to connect with CSL leaders and learn more about why we might be your partner of choice. @[Hervé Gisserot], @[Michael Wilson](urn:li:person:0-yCZLJeLK), @[Debbie Drane](urn:li:person:KgD-0bKnui), @[Stephen Pitt, Ph.D.](urn:li:person:Z-Tg0pWw64), @[Con Panousis](urn:li:person:3kvZmj4rMv), @[Jarrat Jordan](urn:li:person:3Xmx5rsKwe), @[Sophie (Yu) Kuang](urn:li:person:bpTth6Dtqw)
CSL's 2026 Full Year
Financial Results
We have announced our Full Year Financial Results
for the period ending 30th June 2026.
Would you like to read our 2026 Annual Report? Click here to view or download the Annual Report → | Like to learn more about Our Impact? Click here to view or download the 2025 Impact Report →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia
Today, we announced our FY26 full-year results. FY26 was a year of transition and setting a path to return to sustainable growth. To learn more about our results and how we’ve simplified the business and invested in our commercial capabilities, visit our Investor Centre: https://investors.csl.com/ #CSL
"I’ve always believed that the patient is my true employer. The company is the platform that allows me to deliver on that responsibility. That’s why choosing where to work has always been incredibly important to me ... ultimately, there is always a patient waiting. And they are the ones that matter the most." Rishi leads a global network of experts ensuring patients worldwide have access to safe, effective CSL medicines. Read Rishi's story: https://lnkd.in/et-3RGzZ #CSL #PeoplePoweringScience
Melissa’s story reminds us that no one should face a rare disease alone. At CSL, we’re proud to partner with patient communities and advocacy organizations that help foster connection, provide support, and amplify the voices of those living with hereditary angioedema and other rare conditions. #CSL #PatientAdvocacy #PatientFocus
We’re proud to share that we’ve been nominated by The Galien Foundation in the Best Biotechnology Product category for the 2026 #PrixGalien USA Awards. Among the life sciences industry’s most respected honors, these awards recognize outstanding innovation in improving human health. It's a privilege to be recognized alongside fellow nominees representing some of the field’s most impactful advancements. #CSL
How does data power the future of medicine? For Sunil, it’s about making science easier to do. By building systems that improve how researchers access and use data, his team helps accelerate discovery, especially in rare disease research, where every insight matters. Because when scientists have what they need, innovation moves faster. Explore R&D opportunities at CSL: https://lnkd.in/dbhEc33c #DataScience #Innovation #PeoplePoweringScience #CSLCareers #PromisingFutures #CSL
"Just as it’s easier to cook in a kitchen that has clearly identified, accessible, and reliable ingredients, scientific work depends on data that is relevant, organised, and traceable. This is where I see our greatest opportunity and responsibility: building data banks for rare diseases.” Sunil and his team are building a strong foundation of well organised data and analytics platforms to help scientists develop new medicines for rare and serious diseases. Read Sunil's story here: https://lnkd.in/et-3RGzZ #CSL #PeoplePoweringScience
We're sharing an important further update for the ANCA-associated vasculitis community. We recognize this may be difficult and we are committed to supporting patients, caregivers, and healthcare professionals throughout this process. Please read our full community letter for additional information: https://bit.ly/3SkHcjb
Every breakthrough begins with people who refuse to give up. At CSL, we’re inspired every day by the resilience of those living with rare and serious diseases. Their experiences continue to shape our research, deepen our understanding and strengthen our commitment to improving lives. #CSL #RareDisease #Motivation
What helps turn scientific discovery into therapies for patients? For Hanna Sundström, it starts with curiosity, collaboration and solving complex scientific challenges. At CSL, she helps guide therapies through regulatory and clinical pathways — connecting research, strategy and global collaboration to help move innovation forward. Because science can have its greatest impact when it reaches the people who need it. Discover what’s possible in R&D at CSL: https://lnkd.in/dbhEc33c #PeoplePoweringScience #CSLCareers #Innovation #Research #CSL